A clinically integrated network (CIN) is a group of independent providers that follow shared clinical standards, measure outcomes together, and contract with payers as one organization. Joining one makes sense for a physical, occupational, or speech therapy practice that can meet those standards and produce the outcomes data the network needs to prove its value. It does not make sense for a practice that only wants a better fee schedule.
That second point is where most practice owners should start. CINs do not reward volume. They reward practices that can show, with data, that their patients finish care and get better.
Key takeaways
A clinically integrated network is a structured alliance of providers (hospitals, clinics, or independent practices) that agree to common clinical protocols, share performance data, and pursue a collective payer strategy.
The word that matters is "integrated." Being on a referral list is not integration. Members of a true CIN change how they practice, measure themselves against one another, and accept consequences when they fall short.
CINs are organized in four common ways:
The type matters because it determines who writes the protocols, who controls the payer contracts, and how much say your practice has in both.
A CIN is a collaborative network focused on coordinating care and improving quality. An accountable care organization (ACO) is a formal structure that takes on financial risk for a defined patient population, mostly within Medicare programs.
The practical difference for a practice owner is flexibility. A CIN can contract under many arrangements, including commercial payers and employers. An ACO is built around risk-bearing contracts with a defined population.
| Clinically Integrated Network (CIN) | Accountable Care Organization (ACO) | |
|---|---|---|
| Core purpose | Coordinate care and improve quality across members | Take financial accountability for a defined population |
| Financial risk | Varies by contract | Central to the model |
| Who it contracts with | Commercial payers, employers, government programs | Primarily Medicare, some commercial payers |
| Flexibility | High | More structured |
| Data requirements | Shared quality and outcomes data | Shared quality and cost data |
Independent practices cannot negotiate with payers as a group on their own, because under federal antitrust law that is treated as price-fixing. A properly structured CIN can contract collectively because it brings a genuinely new and more efficient way of delivering care to the market, and the collective contract is necessary to make that integration work.
That permission comes with conditions:
Regulators evaluate a CIN under what antitrust lawyers call the rule of reason. In plain terms, the network's pro-competitive activities are weighed against its anti-competitive effects, and the pro-competitive side has to outweigh the other.
On the pro-competitive side of the scale: shared clinical protocols that reduce unwarranted variation, outcomes measurement that payers can verify, care coordination that keeps patients from dropping out of treatment, and a new product (an integrated network) that did not exist before.
On the anti-competitive side: the fact that independent competitors are agreeing on contract terms with payers.
The weighing is not a formality. A network that collects dues and negotiates contracts but never changes how its members practice has nothing to put on the pro-competitive side of the scale. That is why the obligations in the next section exist. They are not bureaucracy. They are the evidence that makes the network legal.
In February 2023, the Department of Justice and the Federal Trade Commission withdrew their 1996 health care antitrust policy statements, which had described "safety zones" of conduct the agencies generally would not challenge. Without those safety zones, every CIN is evaluated on its own facts under the rule of reason described above. If you are forming a CIN or signing onto a new one, legal review is not optional.
Joining a CIN is an operational commitment, not a membership card. Most networks expect four things:
The American Medical Association has noted that the time, effort, and financial commitment required for clinical integration are significant. Go in with eyes open.
Three trends make 2026 the year to take CINs seriously.
Musculoskeletal spending is under pressure. Employer-direct contracting, value-based MSK bundles, and risk-bearing primary care partnerships increasingly pay for population-level outcomes rather than visit volume. Practices that position themselves as population health partners, not downstream referral destinations, are building a more durable place in the market.
Payers are comparing traditional therapy against digital models. Virtual and app-based MSK programs are pitching payers on lower cost per member, and payers are listening. A practice that cannot show its own outcomes data risks being routed around.
Value-based payment is reaching MSK. The CMS ACCESS Model includes chronic musculoskeletal pain among its focus conditions and ties payment to outcomes. It is not a CIN, but it shows where payer incentives are heading.
CINs run on data. To keep their payer contracts, they have to show that integration reduces variation or improves quality in ways payers can verify. That same data is what goes on the pro-competitive side of the scale.
Remote Therapeutic Monitoring produces exactly that kind of evidence between visits. A monitored patient reports how their recovery is going, how pain and function are trending, what is getting in the way, and what changed since the last visit. Over a plan of care, that becomes a continuous record of outcomes rather than a snapshot at discharge.
The record is real. SaRA's analysis of more than 12,000 monitored patients over four years found that 78% reported improved home exercise adherence.
That gives a practice two advantages at once. RTM builds the outcomes record a CIN needs, whether you are applying to join one or already a member. It also generates billable revenue under CPT codes 98975 through 98985 while you build that record.
Get clear, written answers to these six before you sign:
A clinically integrated network is a group of providers, which can include PT, OT, and SLP practices, that follow shared clinical protocols, share outcomes data, and are measured on quality so they can contract with payers collectively.
Not on their own. Joint rate negotiation among independent practices is generally treated as price-fixing under antitrust law. A properly structured CIN can contract collectively because its members are clinically integrated and the price terms support that integration.
Under the rule of reason, a CIN's pro-competitive activities (shared protocols, verified outcomes, care coordination) are weighed against its anti-competitive effects (competitors agreeing on contract terms). The pro-competitive benefits must outweigh the anti-competitive effects.
A CIN is a collaborative network focused on coordinating and improving care, and it can contract with commercial payers and employers. An ACO is a formal structure that takes on financial risk for a defined population, mostly within Medicare programs.
Most CINs require adherence to shared clinical protocols, regular data reporting, compatible technology, and accountability for performance, including the possibility of removal for underperformance.
RTM captures between-visit data on how a patient's recovery is going, including pain, function, and what is getting in the way. That outcomes record is the measurable quality CINs and payers look for, and it generates RTM revenue while the practice builds it.
Yes. SaRA Health launched CARE, a clinically integrated network built for independent physical, occupational, and speech therapy practices, to give those practices a seat at the table on how care between visits is delivered and measured. CARE is RTM platform agnostic.
Ready to turn your patients' progress into outcomes data payers can see? Book a SaRA demo
Running an independent PT, OT, or SLP practice and want a seat at the table? Learn about CARE